TP53 and diffuse large B-cell lymphoma: SNVs in diffuse large B-cell lymphomas that disrupt the miR-125b-binding site within the 3′-UTR of TP53 are associated with better prognosis of patients owing to de-repression of a tumor suppressor TP53 (Li et al., 2013b).